Exact Sciences : Madison School Nurses Tour COVID-19 Lab
January 03, 2022 at 02:29 pm
Share
Madison School Nurses Tour COVID-19 Lab
On November 1, 20 school nurses from the Madison Metropolitan School District toured the COVID-19 testing operations at Exact Sciences' Discovery Campus on the city's near west side. It was the first time these dedicated professionals got to see what happens to nasal swab-collected samples they send in for testing.
Exact Sciences began developing a COVID-19 test in the early days of the pandemic to keep its employees safe and cancer tests operational. This effort quickly grew to include supporting local communities by providing needed testing capacity to the State of Wisconsin.
Nurses have been on the front-line since the start of the pandemic, working tirelessly to keep students and faculty safe. In fact, when Exact Sciences began processing COVID-19 tests, school nurses were among those who worked with the company and public health officials to create an efficient process for sample collection, transportation, and results reporting.
Exact Sciences has processed more than 3 million COVID-19 test results, the vast majority supporting public health efforts in Wisconsin. In the past six months alone, Exact Sciences' teams handled more than 35,000 COVID tests for 450 K-12 schools throughout the state. Results are typically delivered within 48 hours of a sample reaching the company's lab in Madison. Lab team members work long hours, knowing each result impacts the wellness of students, faculty, families, and communities.
Related Content
Community Engagement
Supporting Afghan Refugee Efforts
Supporting Afghan Refugee Efforts...
Community Engagement
Going The Extra Mile
Our 2021 race season participants share what inspires them...
Community Engagement
Exact Sciences Hosts Maydm Interns
This summer, Exact Sciences worked with Maydm, a community partner, to host four interns interested in science, technology, engineering and math (STEM) fields. ...
Attachments
Original Link
Original Document
Permalink
Disclaimer
EXACT Sciences Corporation published this content on 03 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 January 2022 19:28:08 UTC.
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Companyâs products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Companyâs flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patientâs breast tumor tissue.
EXACT SCIENCES CORPORATION 
